Asoprisnil Explained

Asoprisnil (INN; developmental code name J-867) is a synthetic, steroidal selective progesterone receptor modulator that was under development by Schering and TAP Pharmaceutical Products for the treatment of uterine fibroids.^[1] In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.^[2]

See also

• Asoprisnil ecamate
• Mifepristone
• Ulipristal acetate
• Vilaprisan

Notes and References

1. DeManno D, Elger W, Garg R . Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy . Steroids . 68 . 10–13 . 1019–32 . 2003 . 14667995 . 10.1016/j.steroids.2003.09.008. 23074350 . etal.
2. http://www.schering.de/html/en/50_media/download/_files/2005/fin_rep/interim/05q3_areas_en.pdf Schering Interim Report Q1-3 2005